Leaders look for ways to revitalize State Street shopping corridor
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Wanted: 700 workers for tri-county tech jobs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Santa Maria embraces more development
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
More housing key to health of tri-county economy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thornberg: Slower growing economy doesn’t mean recession near
The eight-year trend of economic growth in California and the Central Coast does not necessarily mean a recession is coming, according to economists who spoke at the Central Coast Economic Forecast on Nov. 3 in San Luis Obispo. A common belief is that the economy has a life cycle that inevitably switches back and forth Read More →
Available retail space on State Street growing
There are twice as many available retail spaces on State Street than there were in 2015 and available retail square footage has almost tripled since 2016, according to speakers at the 10th annual Radius Real Estate and Economic Forecast at the Fess Parker — A Doubletree by Hilton Resort on Nov 1. The event featured Read More →
Amgen product sales slip but income stays steady
Net income at biotech giant Amgen stayed flat for the third quarter, despite a slight downtick in revenues to $5.8 billion, the company reported Oct. 25. Product sales saw a slight decline, including Neupogen, Epogen and its blockbuster rheumatoid arthritis drug Enbrel, which fell 6 percent, but net income stayed steady at a little more Read More →
